11/08/2019
4:17 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Five Prime Therapeutics (Subject)
| Form SC 13G/A
| |
11/07/2019
6:22 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2019
4:16 PM | Five Prime Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2019
3:11 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2019
5:24 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2019
4:43 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2019
4:30 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2019
3:12 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2019
3:06 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2019
6:30 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2019
4:40 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2019
3:42 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2019
3:42 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Five Prime Therapeutics (Subject)
| Form SC 13G/A
| |
09/19/2019
3:32 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2019
12:20 PM | Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2019
12:18 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2019
12:15 PM | Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2019
12:12 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
11:15 PM | Five Prime Therapeutics (Filer)
| Form EFFECT
| |
08/22/2019
5:50 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
3:07 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2019
3:47 PM | Five Prime Therapeutics (Filer)
| Form S-3/A
| |
08/07/2019
7:48 PM | Five Prime Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2019
3:17 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2019
9:17 AM | Five Prime Therapeutics (Filer)
| Form CT ORDER
| |
08/02/2019
9:11 AM | Five Prime Therapeutics (Filer)
| Form CT ORDER
| |
08/02/2019
9:00 AM | Five Prime Therapeutics (Filer)
| Form CT ORDER
| |
07/31/2019
3:10 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2019
3:08 PM | Five Prime Therapeutics (Subject)
| Form SC TO-I/A
| |
07/10/2019
1:58 PM | Five Prime Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
07/01/2019
5:08 AM | Five Prime Therapeutics (Subject)
| Form SC TO-I
| |
06/28/2019
3:07 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2019
3:35 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2019
3:30 PM | Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2019
3:28 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2019
3:25 PM | Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2019
3:10 PM | Five Prime Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2019
3:08 PM | Five Prime Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/24/2019
3:11 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2019
5:37 PM | Five Prime Therapeutics (Issuer)
Nicholson Garry A (Reporting)
| Form 3/A
| |
06/12/2019
5:28 PM | Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
5:26 PM | Five Prime Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
5:23 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
5:21 PM | BERGER FRANKLIN M (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
5:18 PM | Five Prime Therapeutics (Issuer)
Nicholson Garry A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
5:15 PM | Five Prime Therapeutics (Issuer)
Jensen Peder (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
5:11 PM | Dhingra Kapil (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:09 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2019
12:53 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2019
5:42 PM | Five Prime Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2019
5:34 PM | Five Prime Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/16/2019
5:29 PM | Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2019
3:11 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2019
4:11 PM | Five Prime Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/09/2019
3:31 PM | Five Prime Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2019
3:11 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2019
12:21 PM | Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
| Form 3/A
| |
05/02/2019
12:15 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 3/A
| |
05/02/2019
12:12 PM | Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
| Form 3/A
| |
04/29/2019
5:09 AM | Five Prime Therapeutics (Filer)
| Form DEF 14A
| |
04/12/2019
5:10 AM | Five Prime Therapeutics (Filer)
| Form PRE 14A
| |
04/04/2019
3:43 PM | Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
| Form 4/A
| |
04/03/2019
3:41 PM | Five Prime Therapeutics (Filer)
| Form CT ORDER
| |
03/19/2019
9:56 AM | Five Prime Therapeutics (Filer)
| Form CT ORDER
| |
03/18/2019
3:07 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2019
5:21 PM | Five Prime Therapeutics (Issuer)
White David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
5:12 PM | Five Prime Therapeutics (Issuer)
White David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/04/2019
3:06 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2019
5:15 PM | Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4/A
| |
02/27/2019
7:07 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2019
7:01 PM | Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2019
6:58 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2019
6:53 PM | Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2019
6:49 PM | Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2019
3:11 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2019
3:04 PM | Five Prime Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13G/A
| |
02/13/2019
10:52 AM | Five Prime Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
02/13/2019
5:50 AM | Five Prime Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A
| |
02/12/2019
8:43 AM | Five Prime Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
02/11/2019
8:29 AM | Five Prime Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/07/2019
4:24 PM | Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2019
4:21 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2019
4:18 PM | Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2019
4:14 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2019
3:08 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2019
5:07 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
5:10 AM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2018
3:10 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2018
6:21 PM | Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2018
6:10 PM | Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2018
7:32 PM | Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2018
8:05 AM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2018
3:00 PM | Five Prime Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13G
| |
10/04/2018
4:09 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Five Prime Therapeutics (Subject)
| Form SC 13G/A
| |
10/02/2018
5:50 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2018
5:46 PM | Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2018
5:43 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2018
11:12 AM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2018
11:58 AM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2018
11:29 AM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
